Head and Neck Cancer News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

Dr. Bauml on HPV Vaccination for Head and Neck Cancer - OncLive - OncLive



Dr. Bauml on HPV Vaccination for Head and Neck Cancer - OncLive 
OncLive
Joshua Bauml, MD, assistant professor, Perelman School of Medicine, University of Pennsylvania, discusses HPV vaccination for patients with HPV-related head and neck cancer.

and more » 


Head and Neck Cancer Pipeline Report 2017 - ResearchAndMarkets.com - Business Wire (press release)



Head and Neck Cancer Pipeline Report 2017 - ResearchAndMarkets.com 
Business Wire (press release)
However, the drug experiences limited off-label use due to its category 2B recommendation from the National Comprehensive Cancer Network, and is under Phase III development for use in emerging markets. Imfinzi is expected to be the third immunotherapy ...
Head and Neck Cancer Marketed Drugs Research Report 2017 ... PharmiWeb.com (press release)
Head and Neck Cancer Treatment China Market Research ... The Financial
Head and Neck Cancer Treatment Report 2017: Treatment, Epidemiology, Marketed Drugs, Pipeline & Forecast ... Digital Journal

all 5 news articles » 


New developments in the management of head and neck cancer ? impact of pembrolizumab - Dove Medical Press



New developments in the management of head and neck cancer ? impact of pembrolizumab 
Dove Medical Press
Abstract: Head and neck squamous cell carcinoma (HNSCC), a heterogeneous group of upper aerodigestive tract malignancies, is the seventh most common cancer worldwide. Tobacco use and alcohol consumption were the most identified risk factors of HNSCC ...

and more » 


Reduced RT Feasible in Chemo-Sensitive HPV-Associated Head and Neck Cancer - Cancer Network



Reduced RT Feasible in Chemo-Sensitive HPV-Associated Head and Neck Cancer 
Cancer Network
?Head and neck tumors that are caused by HPV respond well to therapy and can be cured reliably,? said Tanguy Seiwert, MD, of the University of Chicago Medicine, in a press release. ?In fact, the effectiveness of combined treatment with radiation and ...

 


Novel De-escalation Approach for HPV+ Head and Neck Cancer - Medscape



Medscape
 
Novel De-escalation Approach for HPV+ Head and Neck Cancer 
Medscape
A study of a novel approach to de-escalating treatment for HPV-positive head and neck cancer shows excellent pathologic complete response and survival outcomes.

and more » 


Depression Worsens Outcomes in Head and Neck Cancer, But Not ... - Curetoday.com



satPRnews
 
Depression Worsens Outcomes in Head and Neck Cancer, But Not ... 
Curetoday.com
A recent study showed that patients with head and neck cancer who had greater depressive symptoms had shorter survival, higher rates of chemoradiation interruption and poorer treatment response. However, there are ways to manage these symptoms.
Head and Neck Cancer Treatment Market 2018 to 2025 Market News Access

all 11 news articles » 


Imfinzi Seen to Safely Help Certain Patients with Advanced Head and Neck Cancer in Phase 2 Trial - Immuno-Oncology News



Immuno-Oncology News
 
Imfinzi Seen to Safely Help Certain Patients with Advanced Head and Neck Cancer in Phase 2 Trial 
Immuno-Oncology News
The CONDOR trial (NCT02319044) enrolled 267 people with advanced head and neck cancers ? those of the oral cavity, oropharynx, hypopharynx or larynx ? who had failed to respond to prior platinum-based chemotherapy. In the majority of patients (64 ...

 


Opdivo Safe for Head and Neck Cancer Patients on Radiation and Chemo, Phase 1 Trial Shows - Immuno-Oncology News



Immuno-Oncology News
 
Opdivo Safe for Head and Neck Cancer Patients on Radiation and Chemo, Phase 1 Trial Shows 
Immuno-Oncology News
?Thus, we are compelled to evaluate whether adding immunotherapy to the initial treatment of head and neck cancer could prevent these relapses from happening.? The RTOG Foundation 3504 study (NCT02764593) assessed the safety and feasibility of adding ...

 


Adding Nivolumab to Standard First-Line Therapy Feasible in ... - Cancer Network



Adding Nivolumab to Standard First-Line Therapy Feasible in ... 
Cancer Network
An early phase trial found that it is feasible to combine nivolumab immunotherapy with radiation therapy and chemotherapy in patients with newly diagnosed local-regionally advanced head and neck cancers. 1.

and more » 


Are Oral Microbes Linked to Head and Neck Squamous Cell Cancer Risk? - Medical News Bulletin



Medical News Bulletin
 
Are Oral Microbes Linked to Head and Neck Squamous Cell Cancer Risk? 
Medical News Bulletin
Every year, there are over half a million new cases of head and neck cancers (mouth and throat) worldwide. About 85% of these are squamous cell cancers, meaning that they develop in the lining cells of the mouth and throat. Researchers in the US ...